162 related articles for article (PubMed ID: 38194709)
21. Construction of a necroptosis-related lncRNA signature to predict the prognosis and immune microenvironment of head and neck squamous cell carcinoma.
Huang J; Xu Z; Teh BM; Zhou C; Yuan Z; Shi Y; Shen Y
J Clin Lab Anal; 2022 Jun; 36(6):e24480. PubMed ID: 35522142
[TBL] [Abstract][Full Text] [Related]
22. MTHFD1L as a folate cycle enzyme correlates with prognostic outcome and its knockdown impairs cell invasive behaviors in osteosarcoma via mediating the AKT/mTOR pathway.
Wang L; Yang Y; Wang XM; Wang CQ; Zhang YM; Li BL
J Recept Signal Transduct Res; 2020 Dec; 40(6):584-590. PubMed ID: 32456526
[TBL] [Abstract][Full Text] [Related]
23. Long non-coding RNA SNHG6 promotes the growth and invasion of non-small cell lung cancer by downregulating miR-101-3p.
Li K; Jiang Y; Xiang X; Gong Q; Zhou C; Zhang L; Ma Q; Zhuang L
Thorac Cancer; 2020 May; 11(5):1180-1190. PubMed ID: 32147945
[TBL] [Abstract][Full Text] [Related]
24. A novel necroptosis-related lncRNAs signature for survival prediction in clear cell renal cell carcinoma.
Zhao L; Luo H; Dong X; Zeng Z; Zhang J; Yi Y; Lin C
Medicine (Baltimore); 2022 Sep; 101(39):e30621. PubMed ID: 36181033
[TBL] [Abstract][Full Text] [Related]
25. Necroptosis-related lncRNA signature predicts prognosis and immune response for cervical squamous cell carcinoma and endocervical adenocarcinomas.
Lin Z; Zou J; Sui X; Yao S; Lin L; Wang J; Zhao J
Sci Rep; 2022 Sep; 12(1):16285. PubMed ID: 36175606
[TBL] [Abstract][Full Text] [Related]
26. A novel necroptosis-related lncRNA signature predicts the prognosis and immune microenvironment of hepatocellular carcinoma.
Wang J; Shen B; Liu X; Jiang J
Front Genet; 2022; 13():985191. PubMed ID: 36267408
[TBL] [Abstract][Full Text] [Related]
27. Long non-coding RNA PVT1 promotes osteosarcoma development by acting as a molecular sponge to regulate miR-195.
Zhou Q; Chen F; Zhao J; Li B; Liang Y; Pan W; Zhang S; Wang X; Zheng D
Oncotarget; 2016 Dec; 7(50):82620-82633. PubMed ID: 27813492
[TBL] [Abstract][Full Text] [Related]
28. Long Non-Coding RNA Urothelial Carcinoma Associated 1 Promotes Proliferation, Migration and Invasion of Osteosarcoma Cells by Regulating microRNA-182.
Li Q; Xing W; Gong X; Wang Y
Cell Physiol Biochem; 2018; 51(3):1149-1163. PubMed ID: 30481751
[TBL] [Abstract][Full Text] [Related]
29. Predicting Prognosis and Distinguishing Cold and Hot Tumors in Bladder Urothelial Carcinoma Based on Necroptosis-Associated lncRNAs.
Liu D; Xu S; Chang T; Ma S; Wang K; Sun G; Chen S; Xu Y; Zhang H
Front Immunol; 2022; 13():916800. PubMed ID: 35860239
[TBL] [Abstract][Full Text] [Related]
30. Construction of a novel necroptosis-related lncRNA signature for prognosis prediction in esophageal cancer.
Liu Y; Hao H; Kang L; Zheng G; Guo X; Li B; Zhao H; Hao H
BMC Gastroenterol; 2022 Jul; 22(1):345. PubMed ID: 35840890
[TBL] [Abstract][Full Text] [Related]
31. A necroptosis-related lncRNA signature was identified to predict the prognosis and immune microenvironment of IDH-wild-type GBM.
Song C; Zhu L; Gu J; Wang T; Shi L; Li C; Chen L; Xie S; Lu Y
Front Oncol; 2022; 12():1024208. PubMed ID: 36601479
[TBL] [Abstract][Full Text] [Related]
32. Downregulated Long Non-Coding RNA MSC-AS1 Inhibits Osteosarcoma Progression and Increases Sensitivity to Cisplatin by Binding to MicroRNA-142.
Zhang L; Zhao G; Ji S; Yuan Q; Zhou H
Med Sci Monit; 2020 Mar; 26():e921594. PubMed ID: 32155139
[TBL] [Abstract][Full Text] [Related]
33. Knockdown of TBRG4 suppresses proliferation, invasion and promotes apoptosis of osteosarcoma cells by downregulating TGF-β1 expression and PI3K/AKT signaling pathway.
Huang F; Zhou P; Wang Z; Zhang XL; Liao FX; Hu Y; Chang J
Arch Biochem Biophys; 2020 Jun; 686():108351. PubMed ID: 32240636
[TBL] [Abstract][Full Text] [Related]
34. Necroptosis-Related LncRNA Signatures for Prognostic Prediction in Uterine Corpora Endometrial Cancer.
Lin Z; Fan W; Sui X; Wang J; Zhao J
Reprod Sci; 2023 Feb; 30(2):576-589. PubMed ID: 35854199
[TBL] [Abstract][Full Text] [Related]
35. A novel necroptosis-related long noncoding RNA model for predicting clinical features, immune characteristics, and therapeutic response in clear cell renal cell carcinoma.
Zhang L; Chen Y; Hu W; Wu B; Ye L; Wang D; Bai T
Front Immunol; 2023; 14():1230267. PubMed ID: 37600792
[TBL] [Abstract][Full Text] [Related]
36. Necroptosis-related LncRNAs in skin cutaneous melanoma: evaluating prognosis, predicting immunity, and guiding therapy.
Liu J; Luo B; Zhang P; Jiang K; Hou Z; Cao X; Tang J
BMC Cancer; 2023 Aug; 23(1):752. PubMed ID: 37580654
[TBL] [Abstract][Full Text] [Related]
37. The LncRNA LINC00963 facilitates osteosarcoma proliferation and invasion by suppressing miR-204-3p/FN1 axis.
Zhou Y; Yin L; Li H; Liu LH; Xiao T
Cancer Biol Ther; 2019; 20(8):1141-1148. PubMed ID: 30975024
[No Abstract] [Full Text] [Related]
38. Clinicopathological and Prognostic Value of Necroptosis-Associated lncRNA Model in Patients with Kidney Renal Clear Cell Carcinoma.
Gu J; He Z; Huang Y; Luan T; Chen Z; Wang J; Ding M
Dis Markers; 2022; 2022():5204831. PubMed ID: 35664432
[TBL] [Abstract][Full Text] [Related]
39. Construction and experimental validation of a necroptosis-related lncRNA signature as a prognostic model and immune-landscape predictor for lung adenocarcinoma.
Zhang T; Hei R; Huang Y; Shao J; Zhang M; Feng K; Qian W; Li S; Jin F; Chen Y
Am J Cancer Res; 2023; 13(9):4418-4433. PubMed ID: 37818057
[TBL] [Abstract][Full Text] [Related]
40. LncRNA SNHG6 promotes breast cancer progression and epithelial-mesenchymal transition via miR-543/LAMC1 axis.
Wang YQ; Huang G; Chen J; Cao H; Xu WT
Breast Cancer Res Treat; 2021 Jul; 188(1):1-14. PubMed ID: 33782812
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]